EXTENDO 944X
EXTENDO 944X Featuring several next gen optimizations, the Extendo 944X telehandler is powered by a standard
Reduce the 85% failure rate in clinical phases with NETRI’s cutting-edge organs-on-chip technology. Our high-throughput data and AI-driven predictive analytics accelerate drug discovery, providing reliable data to enhance research outcomes while seamlessly integrating into your workflows and reducing both costs and time.
NETRI has developed a unique value proposition in the organ-on-chip market : human cell-based assays to catalog and learn the complex language of human neurons and translate for pharmaceutical, nutrition & dermo-cosmetics industries developing treatment across all applications.
Accompanying their clients throughout the development life of their product, by providing predictive datas or platforms to understand modes of action in discovery, preclinical or clinical phases.
The use of human neural circuits coupled to multiple cell types opens the way to more personalized medicine as well as faster and more relevant diagnostics.
12
Patents
50+
People
70+
Clients
NETRI Services combines expert teams, unique know-how, and advanced technologies to facilitate the adoption of neuro-organs-on-chip for any application. We offer translation of partners’ reliable cell lines into our microfluidic devices, interpreting them into relevant readouts.
Designed to accelerate the time-to-market of treatments and products, NETRI Services seamlessly integrates with partners' existing research processes, providing dedicated expert support.
Full support services to set up your team with full in-house capabilities in organs-on-chip. NETRI's Field Application Scientists are on hand from start to finish to help you get the most out of our devices.
R&D & Screening Remote Services to provide predictive datas on toxicity, efficacy and modes of action in discovery & pre-clinical phases.
Applications :
NETRI focus on building the microfluidic architecture and model best suited to your research needs. Understanding your needs, and translating them into the most relevant and reproducible microfluidic devices and/or models for you.
Anticipate the effectiveness of innovative treatments
Accelerate preclinical research phases
Reposition compounds for new indications, while limiting animal testing
The FAQ Page Widget is provided by the SEO Rich Snippets App.
It can be used to enter a series of frequently asked questions with their answers.
The App detects these widgets and creates structured data that can generate rich snippets in Google. Google requires at least 2 questions for this feature.
The FAQ Page Widget is provided by the SEO Rich Snippets App.
It can be used to enter a series of frequently asked questions with their answers.
The App detects these widgets and creates structured data that can generate rich snippets in Google. Google requires at least 2 questions for this feature.
NETRI's compartmentalized and pump-free devices, compatible with your existing lab equipment. These features allow for efficient, scalable compound testing, generating large volumes of data quickly and integrating seamlessly with standard lab setups.
NETRI uses neurons as bio-digital sensors to create digital signatures that reflect a compound's toxicity or efficacy. This innovative method provides detailed, accurate data on how compounds affect innervated target organs, enhancing predictive accuracy in drug testing.
NETRI's digital library compares the digital signatures of new compounds with those of existing ones, including failed clinical trials. This comparison predicts toxicity and efficacy, leveraging historical data to improve decision-making and reduce drug development costs.
We like to innovate as much as you do,
get a call with an expert to benefit from NETRI Services.
Get the latest updates on new products and upcoming sales